---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-23-000055"
form_type: "8-K"
ticker: "HSCS"
cik: "0001468492"
company_name: "HeartSciences Inc."
filed_at: "2023-01-03T23:59:59+00:00"
generated_at: "2026-06-20T20:50:00.846847+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.25
calibrated_materiality_score: 0.25
confidence: "high"
source: SEC EDGAR
---

# Heart Test Laboratories board changes: Kanouff resigns, Wells appointed

## Summary
- Director Patrick Kanouff voluntarily resigned from board and all committees effective Dec 27, 2022.
- David R. Wells appointed to board effective Dec 28, 2022; serves on Audit, Compensation, and Nominating committees.
- Wells is independent; background includes CFO at ENDRA Life Sciences and GHS Investments, founder of Atlas Bookkeeping.

## SEC filing metadata
- accession: 0000950170-23-000055
- form_type: 8-K
- ticker: HSCS
- cik: 0001468492
- company_name: HeartSciences Inc.
- filed_at: 2023-01-03T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.25
- calibrated_materiality_score: 0.25
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1468492/000095017023000055/0000950170-23-000055-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1468492/000095017023000055/hscs-20221227.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-23-000055
- JSON: https://secwatch.observer/filing/0000950170-23-000055.json
- Plain text: https://secwatch.observer/filing/0000950170-23-000055.txt

## Key facts
- Executive change
  Patrick Kanouff resigned as Director at HeartSciences Inc..
  - Action: resigned
  - Role: Director
  source text: Effective December 27, 2022, Patrick Kanouff voluntarily resigned from the Board of Directors (the “Board”) of Heart Test Laboratories, Inc. (the “Company”).
  evidence_url: https://www.sec.gov/Archives/edgar/data/1468492/000095017023000055/0000950170-23-000055-index.htm
- Executive change
  David R. Wells was appointed as Director at HeartSciences Inc..
  - Action: appointed
  - Role: Director
  source text: Effective December 28, 2022, the Board appointed David R. Wells to the Board as a director to fill the vacancy created by Mr. Kanouff’s resignation.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1468492/000095017023000055/0000950170-23-000055-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.